Pharma's Market

SPECIAL REPORT

Healthy Horizons
A brand new series of weekly segments which will explore the macro and micro issues facing the global economy.

MORE HEADLINES

» Markets | Economy | Companies

- Thanksgiving Week Stuffed With Economic News

PHARMA'S MARKET VIDEO

» More

Cholesterol Drug Battle: Niaspan vs. Zetia 16 Nov 2009
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.

Cardiologist Grades Cholesterol Drug Study

16 Nov 2009

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at The Cleveland Clinic, shares his reaction with CNBC's Mike Huckman.

Merck's Cholesterol Drugs Under Pressure

16 Nov 2009

A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Health president.

Cholesterol Drug Battle: Merck vs. Abbott Labs

16 Nov 2009

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, shares her reaction.

Cholesterol Drug Battle 16 Nov 2009
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.

Novo Nordisk CEO on Diabetes Epidemic

13 Nov 2009

Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number could double over the next several years. Lars Sorensen, CEO of Novo Nordisk, the world's largest diabetes care company, talks to CNBC's Mike Huckman.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with Pharma's Market.

CNBC ON DIGG

Getting to the Heart of the Merck-Abbott Embargo Break

Published: Monday, 16 Nov 2009 | 6:11 PM ET

Text Size

By: Mike Huckman
CNBC Correspondent

Live TV is best when things are happening and news is breaking right now. It's immediate and often, hopefully, more compelling.

That's why I and the "Squawk Box" producers were happy with the American Heart Association's plan to lift the news media embargo on the Abbott [ABT Loading... () ] versus Merck [MRK Loading... () ] study at 8 a.m. ET this morning. That'd be right in the middle of their show. Breaking and potentially stock-moving news about huge drugs made by a Dow component. It had all the elements, including controversy about the results.

But it wasn't to be. Sometime Sunday afternoon a major wire service transmitted its embargoed story on the Zetia versus Niaspan study results. It was sent with the usual notation that the piece is under embargo until a certain date and time.

But apparently someone at a relatively small, local midwestern TV station didn't see the admonishment and posted the wire story on its Web site.

After catching or being told about the error, the station took it down almost immediately. But it was too late. "Google Alerts" grabbed it and so did other Web sites. The info was out there for everyone to see. The embargo had been inadvertently broken.

After a meeting of the minds between AHA, "The New England Journal of Medicine," and the two companies involved, it was decided that the embargo would be lifted for everyone else at 6 p.m. ET Sunday.

Reporters for other wire services and media outlets suddenly had to scramble to get their finished stories out a good 14 hours sooner than planned. And with data as important and sensitive as these, that kind of rush job isn't necessarily a good thing.

The upside, perhaps, is that it gave Wall Street analysts several hours to digest and comment on the results for their investor clients, rather than the hour-and-a-half they would've had before the opening bell if the embargo lifted at 8.

This isn't the first time an embargo has been broken and it won't be the last. If the circumstances were different, the AHA and NEJM would likely put the reporter or news outlet that broke it in the naughty corner.

This appears to be an honest mistake.

But it could have been and should have been avoided. I ain't perfect and there but for the grace of God go I, but I don't understand why a major wire service pushed out a story around 18 hours before an embargo lifted. It opens wide the door for an embargo break.

There's no reason that I can see to justify copy going out so early, especially in today's push-button news transmission world.

It needs to stop.

Questions? Comments? and follow me on Twitter at mhuckman